Biology changes the plan
ER, PR, HER2, grade, lymph-node findings, and selected molecular results can change both treatment order and medicine cost.
Breast cancer treatment cost in Thailand
A meaningful estimate starts with the biopsy, stage, grade, ER, PR, and HER2 results. It then maps the order of surgery, chemotherapy, radiotherapy, endocrine or targeted treatment, reconstruction, and surveillance. Thailand has international hospitals in Bangkok and other cities, but a patient should compare the named breast team, pathology service, radiation department, pharmacy, ICU, and home handover rather than a headline package alone.
How much does breast cancer treatment cost in Thailand?
Early-stage breast cancer treatment in Thailand may be planned at THB 330,000 to 825,000, approximately USD 10,000 to 25,000, for surgery, pathology, and a limited treatment sequence. A multimodal plan with surgery, chemotherapy, radiation, and receptor-directed treatment may cost THB 825,000 to 2,310,000, about USD 25,000 to 70,000. Advanced disease, HER2 treatment, immunotherapy, complex reconstruction, or prolonged care can exceed THB 1,650,000 to 4,950,000, about USD 50,000 to 150,000+. These ranges are for planning and are not a medical quote.
USD illustrations use approximately THB 33 per USD, based on the Bank of Thailand exchange-rate context checked in July 2026. Hospitals may bill in THB, USD, or another currency. Confirm the controlling currency, drug-price validity, deposit, refund terms, and exchange-rate adjustment before payment.
Share the basics and the Virello team will guide you toward the next step.
Prefer email? Write to support@virellohealth.com.
Reviewed 2026-07-19
Clinical review: Virello Health Clinical Content Team · Editorial review: Virello Health Research Team
Billing context: THB and USD
ER, PR, HER2, grade, lymph-node findings, and selected molecular results can change both treatment order and medicine cost.
A lumpectomy often connects to radiation, while mastectomy may connect to reconstruction, systemic treatment, or both.
A second review of slides or blocks can be important when the proposed treatment does not match the original report.
Simulation, planning, fractions, reviews, and machine availability may require days or weeks close to the treating center.
A regional center can be suitable for selected phases when the breast team, pharmacy, emergency support, and referral link are documented.
Cost at a glance
The scenarios separate routine and complex pathways. They are not fixed packages and should be replaced by a report-led hospital estimate before travel.
| Scenario | THB | USD | Patient and treatment context | Planning scope |
|---|---|---|---|---|
| Localized surgery-led care | THB 330,000 - 825,000 | USD 10,000 - 25,000 | Confirmed localized disease proceeding to breast-conserving surgery or mastectomy with appropriate node assessment and routine recovery. | The written scope should state breast and axillary operation, anesthesia, pathology, room, medicines, drains, discharge review, and whether radiotherapy is separate. |
| Multimodal early or locally advanced care | THB 825,000 - 2,310,000 | USD 25,000 - 70,000 | A sequence that may include systemic treatment before or after surgery, radiation, endocrine medicine, or HER2-directed therapy. | Price each phase and identify the medicine, dose, cycle count, radiation fractions, pathology, and expected time in Thailand. |
| Advanced or complex biologic pathway | THB 1,650,000 - 4,950,000+ | USD 50,000 - 150,000+ | Recurrent or metastatic cancer, prolonged targeted or immune treatment, complex reconstruction, admission for toxicity, or multiple restaging scans. | A hospital should provide a response-dependent budget instead of promising one fixed total for treatment that may continue for months. |
Usually included
Breast imaging, biopsy review, receptor results, clinical examination, stage discussion, and treatment sequencing consultation.
Send DICOM images and original pathology details before travel.
Lumpectomy or mastectomy, sentinel-node or axillary approach, anesthesia, theatre, routine consumables, and immediate recovery.
Localization, mapping, drain, and margin procedures should be listed.
Only the chemotherapy, endocrine, targeted, immunotherapy, or radiation items written in the quote are included.
A single infusion or fraction is not a complete course.
Wound instructions, drain plan, medicine reconciliation, pathology discussion, and a named follow-up contact.
Lymphedema rehabilitation and long-term surveillance are usually separate.
Confirm separately
Implant, expander, mesh, flap, plastic-surgeon fee, microsurgery, symmetry procedure, and later revision unless specifically named.
Radiation can affect reconstruction timing and risk.
Extra cycles, originator biologics, dose changes, immune treatment, radiation boosts, or re-planning when disease or toxicity changes.
Ask for generic name, brand, dose, interval, and planned duration.
Outside slide review, molecular assays, genomic risk tests, repeat biopsy, liquid biopsy, or tissue transport.
Confirm which laboratory performs and reports each test.
Fever, infection, seroma, lymphedema, thrombosis, wound breakdown, admission, emergency scans, medicines, hotel extension, and local follow-up.
Keep a contingency reserve beyond the base price.
Candidate context
The right treatment sequence depends on invasive or in-situ disease, tumor size and location, nodes, distant spread, grade, ER and PR, HER2, menopausal status, genetic risk, pregnancy or fertility wishes, prior radiation, other illness, and the patient’s preferences. A Thai multidisciplinary team should explain whether surgery comes first, whether medicine should shrink the tumor first, whether radiation follows conservation or mastectomy, and whether reconstruction fits safely. Cost comparison should follow that clinical sequence, not replace it.
The team needs histology, grade, margins when surgery has occurred, ER, PR, HER2, and any pending test that could change treatment.
Mammography, ultrasound, MRI, node imaging, and stage-appropriate body imaging distinguish local disease from regional or metastatic disease.
Breast size, multifocality, prior radiation, genetics, response to preoperative treatment, and patient preference affect conservation or mastectomy.
Heart function, diabetes, bone health, fertility, pregnancy plans, nutrition, mobility, work, caregiving, and emotional support should be discussed.
The patient needs stable symptoms, a named hospital, a companion or local support plan, flexible housing, and a home oncologist for continuity.
Selected patients may have tumor removal with node assessment followed by appropriate radiation and long-term surveillance.
Mastectomy may be followed by no reconstruction, an implant pathway, or delayed tissue reconstruction depending on disease and preference.
Chemotherapy, HER2-directed therapy, endocrine treatment, or immunotherapy may be used first to improve local planning or test response.
When disease has spread, the plan generally emphasizes control, function, symptom relief, and meaningful time rather than a routine curative operation.
Procedure variations
Technique, device, medicine, treatment extent, and prior care can change both the clinical plan and the estimate.
Removes the lesion with a margin and samples the first draining nodes when indicated.
Radiation, margin review, localization, and re-excision policy should be explicit.
May be unilateral or bilateral, simple or skin-sparing, with sentinel sampling or axillary dissection according to findings.
Bilateral surgery is not automatically medically required.
An implant, expander, or tissue flap is placed during the cancer operation.
Discuss infection, loss, radiation effect, and later revision.
Plastic surgery follows cancer surgery and sometimes radiation or systemic treatment.
Budget another operation, recovery, and travel period.
Medicine before surgery may be chosen for tumor biology, size, nodes, or the opportunity to measure response.
A response scan and possible treatment change should be planned.
City comparison
Only cities with evidence for the procedure should appear here. A city range does not prove that every hospital in that city can manage the same case complexity.
| City | Local range | USD range | Capability context | Stay planning |
|---|---|---|---|---|
| Bangkok | THB 396,000 - 4,950,000+ | USD 12,000 - 150,000+ | The widest concentration of breast surgery, pathology, radiotherapy, reconstruction, systemic oncology, and international departments. | Ask whether surgery, radiation, pharmacy, and complication care are at one campus. |
| Chiang Mai | THB 363,000 - 3,960,000+ | USD 11,000 - 120,000+ | University and private services can support selected breast pathways with regional follow-up. | Confirm receptor turnaround, radiation access, and transfer arrangements for deterioration. |
| Phuket | THB 396,000 - 3,630,000+ | USD 12,000 - 110,000+ | International coordination is accessible, while complex reconstruction and advanced drug depth vary by center. | Choose the named cancer hospital first and accommodation second. |
| Pattaya and Chon Buri | THB 363,000 - 3,300,000+ | USD 11,000 - 100,000+ | Eastern Thailand has private and regional oncology services for selected surgery and day-care treatment. | Check whether radiotherapy and emergency admission are onsite or require Bangkok referral. |
| Khon Kaen | THB 346,500 - 3,135,000+ | USD 10,500 - 95,000+ | A northeastern tertiary route may be practical where tumor-board review and pharmacy access are established. | Compare the complete sequence, not only the operation. |
| Hat Yai and Songkhla | THB 346,500 - 3,135,000+ | USD 10,500 - 95,000+ | Southern regional care can suit planned surgery or stable treatment after a specialist review. | Ask how neutropenic fever, wound problems, and treatment delays are handled. |
| Nakhon Ratchasima | THB 330,000 - 2,970,000+ | USD 10,000 - 90,000+ | Large regional population and selected tertiary capabilities may support value-focused care. | Confirm a breast surgeon, medical oncologist, radiation access, and pathology pathway. |
| Chiang Rai | THB 330,000 - 2,805,000+ | USD 10,000 - 85,000+ | Regional assessment and selected treatment may be available; advanced care depends on the hospital. | A written referral route should exist before starting treatment. |
| Udon Thani | THB 330,000 - 2,805,000+ | USD 10,000 - 85,000+ | Planned surgery, infusion, and follow-up may be feasible in a documented regional program. | Clarify language support and which medicines are stocked locally. |
| Rayong | THB 346,500 - 3,135,000+ | USD 10,500 - 95,000+ | Eastern corridor access can support selected care close to major transport routes. | Travel convenience does not substitute for a complete oncology team. |
Estimate variables
In-situ, localized, node-positive, locally advanced, recurrent, and metastatic disease need different durations and combinations.
Ask the team to name the intent and planned phases.
ER, PR, HER2, grade, proliferation, and selected genomic information guide chemotherapy, endocrine, targeted, and immune treatment.
Do not accept a medicine quote before essential pathology is settled.
Conservation, mastectomy, node work, implant, expander, flap, and symmetry surgery change fees and stay.
Keep cancer and plastic-surgery scopes separate.
Generic chemotherapy, biosimilar or originator biologic, dose, body size, cycle count, and treatment months create wide variation.
A per-cycle cost is not a full course.
Simulation, planning, fraction number, boost, nodal fields, follow-up imaging, and long-term medicine add separate phases.
Price from planning through final review.
Medical cost breakdown
Mammography, ultrasound, MRI, image-guided biopsy, localization, and selected axillary studies.
Send source images rather than a report alone.
Histology, grade, ER, PR, HER2, outside review, receptor confirmation, and selected genomic or genetic tests.
A discrepancy should be resolved before treatment.
Stage-appropriate CT, PET-CT or bone assessment plus blood, cardiac, fertility, infection, and pregnancy testing as indicated.
Not every patient needs every scan.
Preoperative assessment, anesthesia, operation, node mapping, pathology, room, nursing, medicines, drains, and discharge planning.
Ask how re-excision or unexpected node surgery is charged.
Named drug, pharmacy preparation, infusion nursing, laboratory review, anti-nausea treatment, port care, and observation.
Drug and administration may be separate.
Consultation, simulation, planning, physics checks, image guidance, fractions, and on-treatment review.
Request a complete course estimate.
Dressings, drain removal, seroma care, pain control, shoulder movement, and early surgical review.
Know the after-hours contact before leaving hospital.
Education, arm assessment, physiotherapy, compression, and treatment for swelling or restricted movement.
Node surgery and radiation affect risk.
Endocrine medicine, biologic treatment, heart or bone monitoring, mammography, oncology visits, and survivorship support.
Budget home-country care as well.
Complete journey budget
Patient and attendant costs should be modeled separately from the medical estimate, with flexible dates and a contingency reserve.
Pathology release, imaging, second opinion, passport and visa documents, medicine list, insurance, and hospital acceptance.
Do not travel without a confirmed sequence.
Accessible housing, companion, meals, transport, dressings, infusion days, radiation attendance, and possible extra nights.
Daily treatment makes location a clinical issue.
Fever review, repeat blood test, wound visit, changed flight, treatment delay, home oncologist, and records handover.
Keep funds and bookings flexible.
Country access
Visa, donor, fertility, medicine, licensing, and treatment-access requirements can change. Confirm current rules with the relevant authority and treating hospital.
Use the Thailand Medical Hub and the hospital international department to confirm the named facility, campus, service line, and patient coordinator.
Healthcare Accreditation Institute information can help interpret hospital certification, but accreditation does not guarantee an individual cancer outcome or a complete quote.
Ask for the radiation oncologist, medical physicist, machine, backup plan, medicine source, approval status, and stock before paying for a course.
Agree pathology slide or block release, courier, consent, chain of custody, privacy, translation, and return of material with both laboratories.
Check the Thailand e-Visa portal or relevant embassy for current medical-treatment entry rules and allow extra time if treatment changes.
Hospital selection
Breast surgeon, medical oncologist, radiation oncologist, radiologist, pathologist, plastic surgeon, genetics, nursing, and rehabilitation as appropriate.
Ask whether the case is discussed before the sequence is fixed.
Confirm receptor testing, HER2 confirmation, margin and node reporting, outside review, tissue storage, and molecular access.
Treatment decisions depend on accurate pathology.
Surgery, reconstruction, chemotherapy, targeted and immune treatment, radiation, pharmacy, emergency admission, and transfusion support.
Avoid disconnected providers with no accountable team.
Neutropenic fever, infusion reaction, thrombosis, infection, wound issue, lymphedema, cardiac monitoring, pain, and nutrition support.
Match resources to the proposed regimen.
Stage, intent, treatment phases, drug names, fractions, admissions, overstay, contingency, and records handover are stated clearly.
A cure percentage is not a substitute for a plan.
Treating team
Explains conservation, mastectomy, node assessment, margins, reconstruction timing, wound care, and the effect of prior treatment.
Interprets stage and biology, selects chemotherapy, endocrine, targeted, or immune treatment, and monitors response and toxicity.
Decide whether radiation is needed, define fields and fractions, plan organs at risk, and maintain delivery quality.
Confirm tissue, receptors, stage evidence, images, localization, response, and the information needed for multidisciplinary decisions.
Plan reconstruction, shoulder function, lymphedema prevention, nutrition, pain, and practical recovery support.
Treatment timeline
Send biopsy, receptors, mammography or MRI, stage scans, prior treatment, medicines, allergies, and questions about sequence.
The team confirms pathology, stage, treatment intent, operation, radiation, systemic medicines, reconstruction, and the estimated THB phases.
Depending on the diagnosis, this may be surgery, preoperative medicine, additional pathology, or a safety assessment before treatment.
Surgery, wound and drain care, pathology review, radiation planning, or a return home for the next phase follows the agreed sequence.
Infusions, tablets, injections, or fractions are monitored with blood tests, response assessment, toxicity review, and adjustments when needed.
The home oncologist receives the final report, medicine plan, imaging schedule, warning signs, and contact route for recurrence or toxicity concerns.
Risks and edge cases
Different receptor or grade results can alter surgery and medicines; treatment should pause for appropriate review when clinically safe.
Keep original slides and blocks documented.
Re-excision, wider node surgery, radiation, or a revised systemic plan may add cost and time.
Ask how the quote handles an unexpected result.
Neutropenic fever or infection can require urgent tests, antibiotics, admission, and a delayed cycle.
Do not manage fever from a hotel without medical advice.
Seroma, infection, wound separation, implant loss, flap problem, or thrombosis may require a different operation.
Cancer and plastic-surgery contingencies should be separate.
Machine maintenance, illness, skin reaction, or a change in the plan may extend stay or require a new schedule.
Ask about backup equipment and missed-fraction policy.
Treatment can affect pregnancy timing and ovarian function; urgent specialist counseling should occur before medicine or radiation.
Travel should not delay a time-sensitive decision.
Destination comparison
The most suitable destination depends on the individual case, required team, treatment availability, travel route, legal eligibility, budget, and continuity after returning home.
| Decision factor | India | Turkey | Thailand | How to use this |
|---|---|---|---|---|
| Care model | Large public, private, and regional oncology network with significant city and hospital variation. | Strong private and university oncology market with international patient packages. | Private international hospitals and public or university tertiary services coexist, with Bangkok offering the widest concentration. | Compare one accountable team, pathology, radiation, drug access, and emergency support. |
| Price structure | Often divided by surgery, cycle, radiation course, and medicine brand. | May be quoted in TRY or foreign currency with package inclusions. | May show THB procedure or day-care packages while excluding prolonged treatment and complications. | Ask for phase-by-phase pricing and overstay terms. |
| Regional choice | Tier 2 cities can handle selected stable phases with the right referral link. | Regional centers may suit surgery or standard oncology after verification. | Regional cities may suit planned care, while complex cases often cluster in Bangkok. | City savings matter only when capability matches the case. |
| Continuity | Useful for South Asian and Gulf travel with many specialist networks. | Convenient for Europe, Central Asia, and Gulf routes. | Well placed for Southeast Asia and selected Asian and Gulf routes. | Choose the destination with a workable return and home-care handover. |
Decision guidance
A named hospital accepts the pathology and images, explains the treatment sequence, supplies THB terms, and connects the patient to a home oncologist.
A coordinator offers a surgery-only price, the report is not checked, drug names are hidden, radiation is unpriced, or no team accepts responsibility for complications.
The center has a documented breast team, pathology, pharmacy, radiation or referral plan, emergency admission, and a safe route to complex care.
There is severe breathlessness, uncontrolled bleeding, confusion, sepsis, chest pain, or another emergency that makes elective travel unsafe.
Reports for review
Prepare the biopsy report, pathology slides or blocks if release is possible, ER and PR, HER2, grade, mammography, ultrasound, MRI, body imaging, blood tests, operative notes, medicines, allergies, pregnancy or fertility information, and a treatment timeline. Ask the Thai hospital for a written plan that names stage, intent, sequence, drug and radiation assumptions, reconstruction, hospital days, THB validity, complication terms, and home follow-up.
Upload medical reportsSend the biopsy report, histology, grade, receptor results, HER2 method, and details of any outside review.
Provide mammography, ultrasound, MRI, biopsy localization, and node images in source format where possible.
Include CT, PET-CT, bone assessment, or other investigations relevant to spread and treatment intent.
List surgery, radiation, chemotherapy, endocrine, targeted, immune, and reconstructive work with dates and response.
Include heart, diabetes, kidney, liver, lung, clotting, infection, pregnancy, fertility, and allergy information.
List prescriptions, supplements, anticoagulants, hormones, steroids, and medicines used during earlier therapy.
Share passport, visa, companion, language, mobility, housing, insurance, and flexible flight information.
Name the local oncologist, surgeon, radiation service, emergency hospital, and person who will support recovery.
Ask which pathology, operation, drug, radiation, reconstruction, and surveillance phases are in the number.
Request generic name, brand or biosimilar, dose, cycle count, administration, and response-dependent changes.
Ask for simulation, planning, fractions, image guidance, treatment review, and missed-visit arrangements.
Confirm records, privacy, cancellation, emergency, refund, hotel extension, and communication after leaving Thailand.
Common questions
Early-stage care may be planned around THB 330,000 to 825,000, while multimodal or advanced care can range from THB 825,000 to 4,950,000 or more depending on stage, drugs, radiation, and reconstruction.
Only when the quotation names the regimen, dose, cycle count, pharmacy, administration, monitoring, and treatment window. Surgery-only prices usually do not include systemic treatment.
It should be priced as a separate complete phase covering consultation, simulation, planning, fractions, image guidance, and treatment review unless the hospital clearly includes it.
Possibly for selected planned phases, but confirm pathology, breast surgery, pharmacy, radiation, emergency admission, and referral capacity before choosing on price.
They guide endocrine, chemotherapy, HER2-directed, or immune treatment, so the medicine duration and price can change substantially.
Not automatically. Implant, expander, flap, plastic-surgery fees, mesh, extra stay, and later revision should be shown separately.
Surgery may fit one trip, but chemotherapy, radiation, targeted therapy, and surveillance often need a longer stay, repeated visits, or home-country continuation.
Contact the treating hospital urgently. Fever during chemotherapy can be an emergency and may require blood tests, antibiotics, admission, and a delayed treatment cycle.
Send pathology and receptors, breast images, stage scans, previous treatment, medicines, comorbidities, allergies, and your treatment questions.
No. Outcome depends on stage, biology, response, treatment completion, and individual health. A credible team explains uncertainty and follow-up rather than guaranteeing a result.
Review and sources
The ranges separate localized surgery, multimodal care, and advanced or prolonged therapy because stage and receptor biology change the sequence. The working conversion is approximately THB 33 per USD using the Bank of Thailand source checked in July 2026. The estimate expands beyond the operation to pathology, biomarkers, radiation, medicines, reconstruction, hotel time, complications, and home follow-up. Thailand Medical Hub, accreditation, and national cancer sources inform provider and context checks; the treating hospital must issue the final THB estimate after reviewing records.
This page is educational and cannot diagnose breast cancer, stage a tumor, select treatment, guarantee an outcome, or establish a hospital’s current authorization. A breast and oncology team should review the pathology and images. Severe bleeding, breathlessness, confusion, fever during treatment, or rapidly worsening symptoms require urgent local medical care.
National Cancer Institute, Thailand · Accessed 2026-07-19
Supports: Cancer service and disease-information context.
National Cancer Institute, Thailand · Accessed 2026-07-19
Supports: National cancer registry and statistics context.
King Chulalongkorn Memorial Hospital · Accessed 2026-07-19
Supports: Multidisciplinary oncology, pathology, radiation, and cellular-care context.
Thailand Medical Hub, Ministry of Public Health · Accessed 2026-07-19
Supports: Medical-service and international care context.
Healthcare Accreditation Institute, Thailand · Accessed 2026-07-19
Supports: Hospital accreditation context.
Bank of Thailand · Accessed 2026-07-19
Supports: THB and USD conversion context.
Royal Thai Government · Accessed 2026-07-19
Supports: Current travel documentation context.
Related planning
Compare another Thailand oncology pathway.
Review a disease-specific treatment sequence.
Understand cycle-based drug and day-care budgeting.
Review biomarker-led immune treatment costs.
Compare India city and treatment ranges.
Compare another international oncology route.
Organize pathology and imaging before a quote.
Request an independent treatment review.
Plan housing and repeated treatment visits.
Plan continuity after returning home.
Questions about an estimate? Email support@virellohealth.com.